The effects of caffeine in adults with neurogenic orthostatic hypotension: a systematic review. [PDF]
Clin Auton Res, 2021 Gibbon JR, Frith J.
europepmc +1 more source
Inhibition of the norepinephrine transporter to treat neurogenic orthostatic hypotension: is this the end of the story? [PDF]
, 2021 Guillaume Lamotte +1 more
openalex +1 more source
Mismatch between subjective and objective dysautonomia
Scientific ReportsAutonomic symptom questionnaires are frequently used to assess dysautonomia. It is unknown whether subjective dysautonomia obtained from autonomic questionnaires correlates with objective dysautonomia measured by quantitative autonomic testing.
Peter Novak +12 more
doaj +1 more source
Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology. [PDF]
Neurol Ther, 2021 Amjad FS, Beinart SC.
europepmc +1 more source
Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort [PDF]
, 2023 Paul A. Beach, J. Lucas McKay
openalex +1 more source
Neurogenic orthostatic hypotension with Parkinson's disease as a cause of syncope: A case report. [PDF]
World J Clin Cases, 2021 Li Y, Wang M, Liu XL, Ren YF, Zhang WB.
europepmc +1 more source
Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. [PDF]
Clin Auton Res, 2021 Kaufmann H +7 more
europepmc +1 more source
Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease [PDF]
, 2017 Daniel O. Claassen, Mark Lew
openalex +1 more source
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment. [PDF]
Neurol Ther, 2022 Hauser RA +6 more
europepmc +1 more source